HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Takashima Selected Research

Lymphatic Metastasis

7/2010Significance of E-cadherin expression in triple-negative breast cancer.
8/2001Proliferating cell nuclear antigen labeling index and p53 expression predict outcome for breast cancer patients with four or more lymph node metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Takashima Research Topics

Disease

11Breast Neoplasms (Breast Cancer)
01/2019 - 03/2000
6Neoplasms (Cancer)
01/2019 - 05/2000
3Infections
07/2003 - 07/2000
2Lymphatic Metastasis
07/2010 - 08/2001
2Dyspepsia (Indigestion)
06/2005 - 01/2004
2Gastritis
01/2004 - 07/2003
2Carcinoma (Carcinomatosis)
09/2001 - 01/2001
1Circulating Neoplastic Cells
01/2018
1Liver Cirrhosis (Hepatic Cirrhosis)
12/2016
1Fibrosis (Cirrhosis)
12/2016
1Chronic Hepatitis C
12/2016
1Chronic Hepatitis B
12/2016
1Triple Negative Breast Neoplasms
07/2010
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
11/2008
1Extensively Drug-Resistant Tuberculosis
11/2008
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2006
1Anaplastic Thyroid Carcinoma
03/2005
1Peptic Ulcer (Peptic Ulcers)
01/2004
1Necrosis
07/2003
1Hyperplasia
04/2002
1Gastroesophageal Reflux (GERD)
04/2002
1Gallstones (Gallstone)
12/2001
1Acute Cholecystitis
12/2001
1Shock
12/2001
1Colic (Abdominal Cramps)
12/2001
1Adenocarcinoma
09/2001
1Prostatic Neoplasms (Prostate Cancer)
09/2001
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2001
1Liposarcoma
09/2001
1Colonic Neoplasms (Colon Cancer)
09/2001
1Hemorrhage
07/2001
1Pain (Aches)
02/2001
1Leukopenia
11/2000
1Tuberculosis (Tuberculoses)
10/2000
1Dermatitis
08/2000
1Hypersensitivity (Allergy)
08/2000
1Pancreatic Ductal Carcinoma
05/2000

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
12/2016 - 09/2001
2Progesterone Receptors (Progesterone Receptor)IBA
03/2013 - 07/2010
2Epidermal Growth Factor (EGF)IBA
03/2005 - 04/2002
1gamma Catenin (Plakoglobin)IBA
01/2018
1wisteria lectinIBA
12/2016
1Indicators and Reagents (Reagents)IBA
12/2016
1Biomarkers (Surrogate Marker)IBA
06/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2013
1Keratin-5 (Keratin 5)IBA
03/2013
1Biological ProductsIBA
03/2013
1human ERBB2 proteinIBA
07/2010
1Cadherins (E-Cadherin)IBA
07/2010
1Isoniazid (Ftivazide)FDA LinkGeneric
11/2008
1Pharmaceutical PreparationsIBA
11/2008
1tandospironeIBA
06/2005
1Famotidine (Pepcid)FDA LinkGeneric
06/2005
1mosaprideIBA
06/2005
1Tyrosine Kinase InhibitorsIBA
03/2005
1Gefitinib (Iressa)FDA Link
03/2005
1ErbB Receptors (EGF Receptor)IBA
03/2005
1AntigensIBA
08/2004
1antigen CYFRA21.1IBA
08/2004
1CarbohydratesIBA
08/2004
1Carcinoembryonic AntigenIBA
08/2004
1Therapeutic UsesIBA
08/2004
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2003
1CytokinesIBA
07/2003
1GastrinsIBA
07/2003
1Peroxidase (Myeloperoxidase)IBA
07/2003
1Cimetidine (Biomet)FDA LinkGeneric
07/2003
1ChemokinesIBA
07/2003
1rebamipideIBA
07/2003
1Colloids (Colloid)IBA
02/2003
1AcidsIBA
04/2002
1LigandsIBA
09/2001
1Messenger RNA (mRNA)IBA
09/2001
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
09/2001
1PPAR gammaIBA
09/2001
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2001
1Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2001
1Immunoglobulin G (IgG)IBA
04/2001
1Lidocaine (Xylocaine)FDA LinkGeneric
02/2001
1Saline SolutionIBA
02/2001
1Codon (Codons)IBA
01/2001
1DNA (Deoxyribonucleic Acid)IBA
01/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2000
1Rifampin (Rifampicin)FDA LinkGeneric
10/2000
1MercuryIBA
08/2000
1HaptensIBA
08/2000
1Lansoprazole (Prevacid)FDA LinkGeneric
07/2000
1Urea (Carbamide)FDA LinkGeneric
07/2000
1MucinsIBA
05/2000
1GadoliniumIBA
03/2000

Therapy/Procedure

5Therapeutics
03/2013 - 11/2000
2Drug Therapy (Chemotherapy)
01/2019 - 06/2006
1Neoadjuvant Therapy
06/2016
1Molecular Targeted Therapy
03/2005
1Ligation
04/2002
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
12/2001
1Punctures
07/2001
1Epidural Injections
02/2001